Summary
- Current Price
- As of today, GALT price is $2.67, down -0.37% on
- Current Price All-Time High
- GALT price is currently -93.03% below its historical high of $38.28 set on
- Market Cap
- GALT current market cap is $172M, up +106.07% over the past 365 days
- PE Ratio
- GALT PE ratio is unknown
- Revenue
- GALT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for GALT has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Galectin Therapeutics Inc. |
| Ticker | NASDAQ: GALT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | galectintherapeutics.com |
| Employees | 15 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.67 | ||
| Price, 1D Change | -0.37% | |
| $172M | ||
| - | ||
| - | ||
| 0.55 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.48 | ||
| EPS, 1Y Change | +36.01% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:6 | |
| Next Split | N/A | N/A |
| Last Ticker Change | PRWP | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.48 | ||
| EPS Estimate | N/A | -$0.41 |
| EPS Est. Change | N/A | +15.41% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $2.67 | ||
| Price Target | - | $11.00 |
| Price Tgt. Change | - | +311.99% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.74 | -$0.74 | -0.65% | |
| -$0.73 | -$0.76 | -3.77% | |
| -$0.49 | -$0.48 | +1.08% | |
| -$0.41 | N/A | +15.41% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +102.27% | ||
| +27.14% | ||
| +106.07% | ||
| +37.59% | ||
| 0.00% | ||
| 0.00% | ||
| +36.01% | ||
| +25.94% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.67 | ||
| $3.95 | ||
| SMA 200 vs Price | +48.12% | |
| $2.96 | ||
| SMA 50 vs Price | +10.90% | |
| 0.55 | ||
| $0.22 | ||
| 41.89 | ||
| 70.02% | ||
| 112.58% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.48 | ||
| -$53.00K | ||
| - | ||
| -$20.09M | ||
| - | ||
| -$30.84M | ||
| - | ||
| -$20.03M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.06 | ||
| 2.42 | ||
| 2.42 | ||
| - | ||
| - | ||
| -32.99 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -1.34 | ||
| -14.39 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$128.41M | ||
| $17.72M | ||
| $19.53M | ||
| $19.44M | ||
| $145.73M | ||
| $8.03M | ||
| $133.76M | ||
| $22.00K | ||
| $3.25M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $30.84M | ||
| $20.03M | ||
| $53.00K | ||
| $0.00 | ||
| $53.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$23.88M | ||
| $0.00 | ||
| $26.48M | ||
| $0.00 | ||
| -$23.88M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with GALT
FAQ
What is the ticker symbol for Galectin Therapeutics Inc.?
The ticker symbol for Galectin Therapeutics Inc. is NASDAQ:GALT
Does Galectin Therapeutics Inc. pay dividends?
No, Galectin Therapeutics Inc. does not pay dividends
What sector is Galectin Therapeutics Inc. in?
Galectin Therapeutics Inc. is in the Healthcare sector
What industry is Galectin Therapeutics Inc. in?
Galectin Therapeutics Inc. is in the Biotechnology industry
What country is Galectin Therapeutics Inc. based in?
Galectin Therapeutics Inc. is headquartered in United States
When did Galectin Therapeutics Inc. go public?
Galectin Therapeutics Inc. initial public offering (IPO) was on September 4, 2002
Is Galectin Therapeutics Inc. in the S&P 500?
No, Galectin Therapeutics Inc. is not included in the S&P 500 index
Is Galectin Therapeutics Inc. in the NASDAQ 100?
No, Galectin Therapeutics Inc. is not included in the NASDAQ 100 index
Is Galectin Therapeutics Inc. in the Dow Jones?
No, Galectin Therapeutics Inc. is not included in the Dow Jones index
When was Galectin Therapeutics Inc. last earnings report?
Galectin Therapeutics Inc.'s most recent earnings report was on May 15, 2025
When does Galectin Therapeutics Inc. report earnings?
The date for Galectin Therapeutics Inc.'s next earnings report has not been announced yet
Data Sources & References
- GALT Official Website galectintherapeutics.com
- GALT Profile on Yahoo Finance finance.yahoo.com/quote/GALT
- GALT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/galt